Bharat Book Bureau Provides the Trending Market Research Report on “Regenerative Medicine Market by Product (Cell Therapy (Autologous, Allogenic), Gene Therapy, Tissue Engineering (Scaffold, Hydrogels), Application (Musculoskeletal, Oncology, Cardiovascular, Ophthalmology, Wound Care), Region - Global Forecast to 2027” under the Life Sciences Market Research Report Category. The report offers a collection of superior Market research, Market analysis, competitive intelligence, and Market reports.

The Regenerative Medicine Market is projected to reach USD 40.6 Billion by 2027 from USD 12.2 Billion in 2022, at a CAGR of 27.2% during the forecast period. Market growth is driven by the availability of funding and rising investments in R&D, increasing clinical trials for stem cell and CAR-T cell therapies, and rising advancements in tissue-engineered products. However, the high treatment cost of RM therapies and commercialization & regulatory are expected to restrain the market growth during the forecast period.

“By application, the musculoskeletal disorders segment accounted for the largest share of the regenerative medicine market”

Based on applications, the regenerative medicine market is segmented into musculoskeletal disorders, wound care, oncology, ocular disorders, dental, and other applications. In 2021, the musculoskeletal disorders segment accounted for the largest market share. This can be attributed to the rising prevalence of orthopedic diseases, the growing geriatric population, the increasing number of stem cell research projects, the growing number of clinical research/trials, and the rich pipeline of stem cell products for treating musculoskeletal disorders.

“Asia Pacific: The fastest-growing region in the regenerative medicine market.”

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, mainly due to increasing research activities in Asian countries, the availability of funding for research, and the growing number of biobanks and research centers are driving the growth of the Asia Pacific regenerative medicine market.

“North America: the largest share of the regenerative medicine market”

North America accounted for the largest share of the regenerative medicine market. Factors such as the to establishment of stem cell banking, tissue engineering , rise in demand for advanced technology-based treatments like stem cell technology, biologics, tissue engineering, and biomaterials.

The primary interviews conducted for this report can be categorized as follows:
•By Respondent: Supply Side- 80% and Demand Side 20%
•By Designation: C-level - 25%, D-level - 20%, and Others - 55%
•By Region: North America -50%, Europe -20%, Asia-Pacific -20%, Latin America -5%, Middle East and Africa – 5%

Major Players
•Novartis AG (Switzerland)
•Biogen (US)
•Sarepta Therapeutics, Inc. (US)
•Gilead Sciences, Inc. (US)
•Amgen, Inc. (US)
•Smith & Nephew plc (UK)
•MEDIPOST Co., Ltd. (South Korea)
•JCR Pharmaceuticals Co., Ltd (Japan)
•Takeda Pharmaceutical Company (Japan)
•CORESTEM Inc (South Korea)
•Vericel Corporation (US)
•MIMEDX (US)
•Organogenesis Inc. (US)
•Medtronic plc (US)
•Orthocell Ltd. (Australia)
•Mesoblast Ltd (Australia)
•BioRestorative Therapies (US)
•Pluri Inc, (Israel)
•Tegoscience (South Korea)
•Anterogen Co., Ltd. (South Korea)
•Bluebird Bio (US)
•APAC Biotech (India)
•Shenzhen Sibiono Genetech Co., Ltd. (China)
•Aspect Biosystems (Canada)
•Athersys, Inc. (US)

Research Coverage:
This report provides a detailed picture of the regenerative medicine market. It aims at estimating the size and future growth potential of the market across different segments, such as the product, applications, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall regenerative medicine market and its segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.

Browse our full report with Table of Content:

https://www.bharatbook.com/report/1388390/regenerative-medicine-market-by-product-cell-therapy-autologous-allogenic-gene-therapy-tissue-engineering-scaffold-hydrogels-application-musculoskeletal-oncology-cardiovascular-ophthalmology-wound-care-region-global-forecast-to

About Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 4,00,000 reports and insights that includes latest Market Study, Market Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.

Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: [email protected]
Website: www.bharatbook.com